Paradigm Asset Management CO LLC Eli Lilly & CO Transaction History

Paradigm Asset Management CO LLC

$266 Million
Q3 2024

A detailed history of Paradigm Asset Management CO LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Paradigm Asset Management CO LLC holds 2,350 shares of LLY stock, worth $1.75 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

2,350

Previous 2,350 -0.0%

Holding current value

$1.75 Million

Previous $2.13 Million 2.16%

% of portfolio

0.78%

Previous 0.85%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $1.45 Million - $1.82 Million	2,000 Added 571.43%	2,350 $2.13 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $88,830 - $118,842	-150 Reduced 30.0%	350 $272,000
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $876,850 - $1.17 Million	-2,500 Reduced 83.33%	500 $234,000
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $964,650 - $1.12 Million	3,000 New	3,000 $1.1 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $901,478 - $1.19 Million	-6,910 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $175,464 - $202,956	-1,200 Reduced 14.8%	6,910 $1.02 Million
Q2 2020 Aug 11, 2020	SELL	$136.42 - $164.18 $95,493 - $114,926	-700 Reduced 7.95%	8,110 $1.33 Million
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $37,422 - $46,350	-350 Reduced 3.82%	8,810 $1.16 Million
Q3 2019 Nov 15, 2019	SELL	$106.79 - $116.16 $213,580 - $232,320	-2,000 Reduced 17.92%	9,160 $1.02 Million
Q2 2019 Aug 08, 2019	SELL	$110.79 - $129.32 $803,227 - $937,570	-7,250 Reduced 39.38%	11,160 $0
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $116,875 - $137,571	-1,050 Reduced 5.4%	18,410 $0
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $1.94 Million - $2.17 Million	-18,300 Reduced 48.46%	19,460 $2.25 Million
Q3 2018 Nov 19, 2018	BUY	$85.86 - $107.31 $751,275 - $938,962	8,750 Added 30.16%	37,760 $0
Q1 2018 May 07, 2018	SELL	$74.21 - $87.6 $140,999 - $166,440	-1,900 Reduced 6.15%	29,010 $0
Q4 2017 Feb 12, 2018	SELL	$81.94 - $87.89 $278,596 - $298,826	-3,400 Reduced 9.91%	30,910 $0
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $2.64 Million - $2.93 Million	34,310	34,310 $0

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Asset Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Asset Management CO LLC with notifications on news.

Account

Paradigm Asset Management CO LLC Eli Lilly & CO Transaction History